Iron Deficiency Anemia Treatment with IV Venofer

Dosing Considerations

For patients with inflammatory bowel disease (IBD), single doses of up to 7 mg/kg iron sucrose have been tested, with repeated dosing limited to 200-300 mg per treatment episode, according to the European Crohn's and Colitis Organisation 1, 2
Total iron needs for IBD patients are based on hemoglobin and body weight, with targets of 1000 mg for Hb 10-12 g/dL and <70 kg, and 1500 mg for Hb 10-12 g/dL and ≥70 kg, as recommended by the European Crohn's and Colitis Organisation 1

The goal of iron deficiency anemia treatment is to normalize hemoglobin levels and replenish iron stores, with a target response of an increase in hemoglobin of at least 2 g/dL within 4 weeks, according to the National Institute for Health and Care Excellence 2, 4
The American Gastroenterological Association recommends monitoring transferrin saturation (TSAT) and serum ferritin, with target values of TSAT ≥20% and serum ferritin ≥100 ng/mL 5

IV iron shows faster response and better tolerance than oral iron, especially in patients with IBD or chronic kidney disease (CKD), with a typical increase in hemoglobin of 5.32 g/dL vs. 3.24 g/dL over 28 days, as reported by the Kidney Disease: Improving Global Outcomes (KDIGO) foundation 1, 2
The American Society of Nephrology notes that common side effects of IV iron include arthralgia (joint pain) and hypotension, with no test dose required for iron sucrose 6, 7

The European Crohn's and Colitis Organisation recommends IV iron as the preferred first-line treatment in patients with clinically active IBD, previous intolerance to oral iron, hemoglobin below 10 g/dL, or those requiring erythropoiesis-stimulating agents 1, 2, 4